Forefront Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.59M | Sell |
3,020
-101
| -3% | -$53K | 1.27% | 29 |
|
|
2025
Q1 | $1.98M | Buy |
3,121
+24
| +0.8% | +$15.2K | 1.83% | 26 |
|
|
2024
Q4 | $2.21M | Buy |
+3,097
| New | +$2.21M | 2.03% | 21 |
|
|
2023
Q3 | $2.55M | Buy |
3,104
+3
| +0.1% | +$2.47K | 3.58% | 11 |
|
|
2023
Q2 | $2.23M | Sell |
3,101
-25
| -0.8% | -$18K | 2.94% | 12 |
|
|
2023
Q1 | $2.57M | Sell |
3,126
-2,003
| -39% | -$1.65M | 3.36% | 10 |
|
|
2022
Q4 | $3.7M | Sell |
5,129
-39
| -0.8% | -$28.1K | 4.98% | 5 |
|
|
2022
Q3 | $3.56M | Sell |
5,168
-112
| -2% | -$77.2K | 4.96% | 6 |
|
|
2022
Q2 | $3.13M | Buy |
5,280
+223
| +4% | +$132K | 4.22% | 8 |
|
|
2022
Q1 | $3.53M | Sell |
5,057
-24
| -0.5% | -$16.8K | 3.49% | 9 |
|
|
2021
Q4 | $3.21M | Buy |
+5,081
| New | +$3.21M | 3.06% | 13 |
|